This case highlights the extreme rarity of primary pericardial lymphoma and underscores the necessity of pericardial biopsy for definitive diagnosis when malignancy is suspected.
Answers are grounded in this paper and cite their sources.
Supports pericardial biopsy when malignancy suspected; leaves open optimal management for this rare entity.
An 81-year-old woman was admitted for right heart failure with complete atrioventricular block. Chest computed tomography (CT) revealed disseminated nodular lesions of the pericardium (Picture a), and positron emission tomography-CT revealed an uptake only along the pericardium (Picture b), with a maximal standardized uptake value of 9.56. A pericardial biopsy showed infiltration by intermediatesized to large atypical lymphocytes expressing the B-cell marker CD20 (Picture c, d). Diffuse large B-cell lymphoma, not otherwise specified (WHO 2016 classification) was diagnosed. Vincristine and prednisolone were initiated for cytoreduction before rituximab treatment, and her condition temporarily improved, but sepsis occurred, and the patient died of multi-organ failure. Primary cardiac lymphoma is extremely rare, accounting for only 0.15% of all non-Hodgkin lymphomas. For only pericardial disease to be demonstrable is even rarer (0.05%) (1, 2). In patients like ours, malignancy should always be considered. Our experience underscores the importance of a pericardial biopsy for a definitive diagnosis.
No takes yet. Share an insight, caveat, or question.
Kinoshita et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: